Ignite Creation Date:
2025-12-26 @ 2:40 PM
Ignite Modification Date:
2025-12-26 @ 2:40 PM
Study NCT ID:
NCT06584006
Status:
RECRUITING
Last Update Posted:
2024-09-19
First Post:
2024-09-02
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Thymalfasin and Recombinant Human IL-2 Injections in Treating Lymphocytopenia for Patients With Malignant Hematological Tumors
Sponsor:
The First Affiliated Hospital of Xiamen University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-09-01
Start Date Type:
ACTUAL
Primary Completion Date:
2027-11-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-02-29
Completion Date Type:
ESTIMATED
First Submit Date:
2024-09-02
First Submit QC Date:
None
Study First Post Date:
2024-09-04
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-05
Last Update Post Date:
2024-09-19
Last Update Post Date Type:
ACTUAL